Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Stryker Facial iD Configurador Universal de Placas: Um Estudo Retrospetivo de Seguimento Pós-Comercialização (UPC)

16 de novembro de 2026 atualizado por: Stryker Craniomaxillofacial

Stryker Facial iD Configurador Universal de Placas: Um Estudo Retrospetivo de Seguimento Pós-Comercialização para Confirmar Segurança e Desempenho

A retrospective post market follow up to confirm safety and performance of Stryker's Facial iD Universal Plate Configurator (UPC) implants in the clinical setting. The study is performed to confirm the product's performance and safety by systematically collecting clinical data on its use.

Visão geral do estudo

Descrição detalhada

This is a retrospective non-interventional post-market follow up aiming at confirming safety and performance of Stryker's Facial iD UPC plating system when used in the clinical setting. This study will include patients who have previously undergone a surgical procedure involving the Study Device, with surgical outcomes evaluated retrospectively. Based on a non-inferiority study power calculation a minimum of 80 patients will be enrolled in the study. Additional patients may be enrolled up to 800 subjects depending on site enrolment rate and patient availability. Up to 3 investigational sites within the United States will participate in this study. The primary outcome parameter evaluating successful fixation or reconstruction of the midface without the need for unplanned revision surgery will be evaluated at all available follow-up timepoints of the included patients.

Tipo de estudo

Observacional

Inscrição (Estimado)

726

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • New York
      • New York, New York, Estados Unidos, 10022
        • New York Center for Orthognathic and Maxillofacial Surgery
      • New York, New York, Estados Unidos, 11042
        • New York Center for Orthognathic and Maxillofacial Surgery, Lake Success, New York

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Método de amostragem

Amostra Não Probabilística

População do estudo

Eligible patients will be identified as having had a surgical procedure involving the Subject Device.

Descrição

Inclusion Criteria:

  1. Patients who received a Stryker UPC plate for osteotomy, stabilization and rigid fixation of maxillofacial fractures or reconstruction as per routine clinical practice
  2. Patients for whom data on the primary outcome variable is available.

Exclusion Criteria:

  1. Patients with non-reducible and unstable fractures at the time of surgery
  2. Patients with fractures of a severely atrophic mandible at the time of surgery
  3. Patients with active local infections at the time of surgery
  4. Patients with metal allergies and/or foreign body sensitivity at the time of surgery
  5. Patients with limited blood supply or insufficient quality or quantity of bone at the time of surgery
  6. Potentially non-compliant patients who are unwilling or incapable of following postoperative care instructions

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Modelos de observação: OTHER
  • Perspectivas de Tempo: RETROSPECTIVE

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Successful fixation or reconstruction of the midface without the need for unplanned revision surgery.
Prazo: Data collected at a single time point per patient in the course of 18 months.

Assessed by reviewing adverse events in patient medical charts at time point after surgery. Used to document whether an unplanned revision surgery was required or not for patients.

Data collected at a single time point per patient in the course of 18 months.

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Infection rate
Prazo: Data collected at time points from patient medical charts in the course of 18 months.

Determined by adverse events reported from patient medical charts.

Data collected at time points from patient medical charts in the course of 18 months.
Intraoperative complications
Prazo: Data collected at a single time point per patient in the course of 18 months.

Determined by adverse events reported from patient medical charts.

Data collected at a single time point per patient in the course of 18 months.
Postoperative complications
Prazo: Data collected at time points per patient in the course of 18 months.

Determined by adverse events reported from patient medical charts.

Data collected at time points per patient in the course of 18 months.
Any known adverse events
Prazo: Data collected at time points per patient in the course of 18 months.

Determined by adverse events reported from patient medical charts.

Data collected at time points per patient in the course of 18 months.
Plate failure
Prazo: Data collected at time points point per patient in the course of 18 months.

Determined by adverse events reported from patient medical charts.

Data collected at time points point per patient in the course of 18 months.
Satisfactory occlusion achieved after additional orthodontic treatment
Prazo: Data collected at a single time point per patient in the course of 18 months.

Data reported in patient medical charts

Data collected at a single time point per patient in the course of 18 months.
Time to return to solid food/normal diet
Prazo: Data collected at a single time point per patient in the course of 18 months.

Time for patient to return to solid food/normal diet post operation (dd)

Data collected at a single time point per patient in the course of 18 months.
Hospitalization time; ICU and normal ward
Prazo: Data collected at a single time point per patient in the course of 18 months.

Time the patient was hospitalized post procedure (dd:hh)

Data collected at a single time point per patient in the course of 18 months.
EuroQol-5 Domain Questionnaire (if available)
Prazo: Data collected at time points per patient in the course of 18 months.

A descriptive system and a visual analogue scale (VAS). The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each with three to five levels of severity. The VAS provides a subjective rating of overall health on a scale from 0 to 100 (higher is better)).

Data collected at time points per patient in the course of 18 months.
Facial Appearance, Quality of Life, and Satisfaction Questionnaire (if available)
Prazo: Data collected at time points per patient in the course of 18 months.

40 independently functioning scales and checklists. Multiple independent scales, each with a 0-100 score, where higher scores indicate better outcomes. Scores are calculated by summing responses on a 4-point Likert scale (e.g., strongly disagree to strongly agree), which are then converted to the 0-100 range. Each scale measures a specific aspect of facial appearance, quality of life, or adverse effects and cannot be summed into a single total score.

Data collected at time points per patient in the course of 18 months.
12-Item Short Form Health Survey (SF-12)
Prazo: Data collected at time points per patient in the course of 18 months.

12 items grouped and scored to produce two separate summary scores: the Physical Component Summary (PCS-12) and the Mental Component Summary (MCS-12). The scale is transformed to a 0-100 range with higher scores indicating better health.

Data collected at time points per patient in the course of 18 months.

Outras medidas de resultado

Medida de resultado
Descrição da medida
Prazo
Primary indication for the surgery / diagnosis
Prazo: Data collected at a single time point per patient in the course of 18 months.

Diagnosis collected from patient medical charts.

Data collected at a single time point per patient in the course of 18 months.
Max follow-up time
Prazo: Data collected at a single time point per patient in the course of 18 months.

Maximum post operative follow up time for patients within standard of care. Reported in patient medical charts during hospital follow up visits.

Data collected at a single time point per patient in the course of 18 months.
Surgical approach
Prazo: Data collected at a single time point per patient in the course of 18 months.

Surgical approach taken for the procedure. Including: transoral; intraoral; maxillary vestibular approach; transbuccal; submandibular; preauricular; other

Data collected at a single time point per patient in the course of 18 months.
Medical conditions
Prazo: Data collected at time points point per patient in the course of 18 months.

Underlying medical conditions and medication that may be related to the device or primary outcome.

Data collected at time points point per patient in the course of 18 months.
Localization of the defect
Prazo: Data collected at a single time point per patient in the course of 18 months.

Area to treated by the device: mandibular ramus; mandibular body; mandibular condyle; parasymphysis; paramedian; Le Fort I; Le Fort II; Le Fort III; others

Data collected at a single time point per patient in the course of 18 months.
Post operative maxillo-mandibular fixation
Prazo: Data collected at a single time point per patient in the course of 18 months.

For patients that receive maxillo-mandibular fixation post operation the length of time after surgery the fixation procedure took place (days).

Data collected at a single time point per patient in the course of 18 months.
Patient Radiation Exposure
Prazo: Data collected at time points per patient in the course of 18 months.

Exposure of patient to radiation therapy within 12 months around the surgery date recorded in patient medical charts (number and type of radiation procedures performed).

Radiation therapy performed on the anatomical area treated with the device.

Any postoperative radiation therapy recorded in patient medical charts.

Data collected at time points per patient in the course of 18 months.
Sterilization method used
Prazo: Data collected at a single time point per patient in the course of 18 months.

Sterilization method used for the device. Qualitative responses from site.

Data collected at a single time point per patient in the course of 18 months.
Fixation system used
Prazo: Data collected at a single time point per patient in the course of 18 months.

System used to fix the device during the procedure. Stryker Universal CMF screws; others

Data collected at a single time point per patient in the course of 18 months.
Tightening of screws
Prazo: Data collected at a single time point per patient in the course of 18 months.

Tools used to fix the device during the procedure. Response options include :

Manual and electric screw driver

Data collected at a single time point per patient in the course of 18 months.
Orthognathic cases
Prazo: Data collected at a single time point per patient in the course of 18 months.

Usage of splints in orthognathic cases.

Data collected at a single time point per patient in the course of 18 months.
Year smoking was stopped
Prazo: Data collected at time points per patient in the course of 18 months.

Year smoking was stopped (YYYY)

Data collected at time points per patient in the course of 18 months.
Smoking frequency
Prazo: Data collected at time points per patient in the course of 18 month

The frequency of exposure to smoking during periods of smoking (average number of cigarettes per day).

Data collected at time points per patient in the course of 18 month
Smoking duration
Prazo: Data collected at time points per patient in the course of 18 month

Duration of smoking (pack years)

Data collected at time points per patient in the course of 18 month
Years of active smoking
Prazo: Data collected at time points per patient in the course of 18 month

Total number of years active smoker (YY)

Data collected at time points per patient in the course of 18 month
Patient weight
Prazo: Data collected at a single time point per patient in the course of 18 months.

Weight (kg, lb)

Data collected at a single time point per patient in the course of 18 months.
Patient height
Prazo: Data collected at a single time point per patient in the course of 18 months.

Height (cm, feet, inches)

Data collected at a single time point per patient in the course of 18 months.
Patient age
Prazo: Data collected at a single time point per patient in the course of 18 months.

Age (years)

Data collected at a single time point per patient in the course of 18 months.
Gender
Prazo: Data collected at a single time point per patient in the course of 18 months

Responses: Male, Female, undifferentiated, unknown

Data collected at a single time point per patient in the course of 18 months

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

18 de novembro de 2024

Conclusão Primária (Estimado)

30 de março de 2027

Conclusão do estudo (Estimado)

30 de março de 2027

Datas de inscrição no estudo

Enviado pela primeira vez

1 de agosto de 2025

Enviado pela primeira vez que atendeu aos critérios de CQ

17 de novembro de 2025

Primeira postagem (Real)

24 de novembro de 2025

Atualizações de registro de estudo

Última Atualização Postada (Real)

17 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

16 de novembro de 2026

Última verificação

1 de abril de 2026

Mais Informações

Termos relacionados a este estudo

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Sim

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever